Praziquantel treatment in trematode and cestode infections: An update

Infection and Chemotherapy

Volumn 45, Issue 1, 2013, Pages 32-43

  Chai, Jong Yil ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Adverse reaction; Cestode; Chemotherapy; Combined therapy; Praziquantel; Trematode

Indexed keywords

ARTEMISININ DERIVATIVE; PRAZIQUANTEL; TRIBENDIMIDINE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANTHELMINTIC ACTIVITY; CESTODE; CESTODIASIS; CLONORCHIASIS; CYSTICERCOSIS; DIARRHEA; DIPHYLLOBOTHRIASIS; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; ECHINOCOCCOSIS; ECHINOSTOMIASIS; FASCIOLA GIGANTICA; FASCIOLA HEPATICA; FASCIOLIASIS; FASCIOLOPSIASIS; GYMNOPHALLOIDIASIS; HEADACHE; HETEROPHYIDIASIS; HISTOPATHOLOGY; HOOKWORM; HOOKWORM INFECTION; HUMAN; HYMENOLEPIASIS; NEODIPLOSTOMIASIS; NONHUMAN; OPISTHORCHIASIS; PARAGONIMIASIS; REVIEW; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SOMNOLENCE; SPARGANOSIS; TAENIASIS; TREMATODE; TREMATODIASIS;

EID: 84879120970     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2013.45.1.32     Document Type: Review

References (96)

1. Andrews P, Thomas H, Pohlke R, Seubert J. Praziquantel. Medl Res Rev 1983;3:147-200.
2. Lee SH, Chai JY. Praziquantel in the treatment of trematode and cestode infections. J Korean Soc Chemother 1985;3:95-118.
3. Keiser J, Utzinger J. Chemotherapy for major foodborne trematodes: a review. Expert Opin Pharmacother 2004;5:1711-26.
4. Chan JD, Zarowiecki M, Marchant JS. Ca(2+) channels and Praziquantel: A view from the free world. Parasitol Int 2012;pii:S1383-5769.
5. Wang W, Wang L, Liang YS. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 2012;111:1871-7.
6. Tinga N, De N, Vien HV, Chau L, Toan ND, Kager PA, Vries PJ. Little effect of praziquantel or artemisinin on clonorchiasis in Northern Vietnam. A pilot study. Trop Med Int Health 1999;4:814-8.
7. Kyung SY, Cho YK, Kim YJ, Park JW, Jeong SH, Lee JI, Sung YM, Lee SP. A paragonimiasis patient with allergic reaction to praziquantel and resistance to triclabendazole: successful treatment after desensitization to praziquantel. Korean J Parasitol 2011;49:73-7.
8. Lee JM, Lim HS, Hong ST. Hypersensitive reaction to praziquantel in a clonorchiasis patient. Korean J Parasitol 1. Andrews P, Thomas H, Pohlke R, Seubert J. Praziquantel. Medl Res Rev 1983;3:147-200.
9. Pax R, bennett JL, Fetterer R. A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Arch Pharmacol 1978;304:309-15.
10. Becker B, Mehlhorn H, Andrews P, Thomas H, Eckert J. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. Z Parasikentd 1980;63:113-28.
11. Mehlhorn H, becker B, Andrews P, Thomas H, Frenkel JK. In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. Arzneimittelfurschung 1981;31:544-54.
12. Mehlhorn H, Kojima S, Rim HJ, Ruenwongsa P, Andrews P, Thomas H, Bunnag B. Ultrastructural investigations on the effects of praziquantel on human trematodes from Asia: Clonorchis sinensis, Metagonimus yokogawai, Opisthorchis viverrini, Paragonimus westermani and Schistosoma japonicum. Arzneimittelforschung 1983;33:91-8.
13. Lee SH. In vitro effects of praziquantel on Fibricola seoulensis. Seoul J Med 1985;26:41-52.
14. Rim HJ, Park HY, Kim SJ, Lee SH. Morphological observations on Clonorchis sinensis obtained from rats treated with praziquantel. Kisaengchunghak Chapchi 1980;18:192-8.
15. Seo BS, Cha IJ, Chai JY, Hong SJ, Lee SH. Studies on intestinal trematodes in Korea XIX. Light and scanning electron microscopy of Fibricola seoulensis collected from albino rats treated with praziquantel. Kisaengchunghak Chapchi 1985;23:47-57.
16. Lee SH, Park HJ, Hong SJ, Chai JY, Hong ST. In vitro effect of praziquantel on Paragonimus westermani by light and scanning electron microscopic observation. Kisaengchunghak Chapchi 1987;25:24-36.
17. Chiu HS, Kim SJ, Rim HJ. Electron-microscopic studies on the effect of praziquantel to Paragonimus westermani. Korea Univ Med J 1982;19:617-30.
18. Horchner F, Langnes A, Oguz T. Die Wirkung von Mebendazole und Praziquantel auf larvale Taenienstadien bei Maus, Kaninchen und Schwein. Tropenmed Parasit 1976;28:44-50.
19. Thomas H, Gönnert R. The efficay of praziquantel against cestodes in animals. Z Parasitenkd 1977;52:117-27.
20. Becker B, Mehlhorn H, Andrews P, Thomas H. Scanning and transmission electron microscope studies on the efficacy of praziquantel on Hymenolepis nana (Cestoda) in vitro. Z Parasikentd 1980;61:121-33.
21. Becker B, Mehlhorn H, Andrews P, Thomas H. Ultrastructural investigations on the effect of praziquantel on the tegument of five species of cestodes. Z Parasikentd 1981;64:257-69.
22. Bylund G, Bång B, Wikgren K. Tests with a new compound (Praziquantel) against Diphyllobothrium latum. J Helminthol 1977;51:115-9.
23. Thomas H, Gönnert R. The efficacy of praziquantel against experimental cysticercosis and hydatidosis (author's transl). Z Parasitenkd 1978;55:165-79.
24. Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, Prichard RK, de Silva NR, Olliaro PL, Lazdins-Helds JK, Engels DA, Bundy DA. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 2010;40:1-13.
25. Vokál I, Jirásko R, Jedliková V, Bártíková H, Skálová L, Lamka J, Hol apek M, Szotáková B. The inability of tapeworm Hymenolepis diminuta and fluke Dicrocoelium dendriticum to metabolize praziquantel. Vet Parasitol 2012;185:168-74.
26. Jeziorski MC, Greenberg RM. Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int J Parasitol 2006;36:625-32.
27. Angelucci F, Basso A, Bellelli A, Brunori M, Pica Mattoccia L, Valle C. The anti-schistosomal drug praziquantel is an adenosine antagonist. Parasitology 2007;134:1215-21.
28. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008;21:659-67.
29. Coulibaly JT, N'gbesso YK, Knopp S, Keiser J, N'Goran EK, Utzinger J. Efficacy and safety of praziquantel in preschoolaged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLoS One 2012;6:e1917.
30. Lovis L, Mak TK, Phongluxa K, Ayé Soukhathammavong P, Vonghachack Y, Keiser J, Vounatsou P, Tanner M, Hatz C, Utzinger J, Odermatt P, Akkhavong K. Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial. PLoS One 2012;6:e1726.
31. Seto EY, Wong BK, Lu D, Zhong B. Human schistosomiasis resistance to praziquantel in China: should we be worried? Am J Trop Med Hyg 2011;85:74-82.
32. Lee SH. Large scale treatment of Clonorchis sinensis infections with praziquantel under field conditions. Arzneimittelforschung 1984;34:1227-30.
33. Bunnag D, Harinasuta T. Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel. Southeast Asian J Trop Med Public Health 1981;12:413-7.
34. Zavokin VD, Zelia OP, Bronshten AM, Sokerina OA, Iarotski LS, Firsova RA, Mikha lov MM, Gerasimov IV. The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 1. The tolerance and efficacy of different doses of biltricide during outpatient use in foci. Med Parasitol (Mosk) 1994;(3):24-7.
35. Rim HJ, Yoo KS. Chemotherapeutc effect of praziquantel (Embay 8440) in the treatment of clonorchiasis sinensis. Korea Univ Med J 1979;16:459-70.
36. Wegner DH. The profile of the trematodicidal compound praziquantel. Arzneimittelforschung 1984;34:1132-6.
37. Farag HF, Ragab M, Salem A, Saden K. A short note on praziquantel in human fascioliasis. J Trop Med Hyg 1986;89:79-80.
38. Farid Z, Kamal M, Mansour N. Praziquantel and Fasciola hepatica infection. Trans R Soc Trop Med Hyg 1989;83:813.
39. Keiser J, Engels D, Büscher G, Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 2005;14:1513-26.
40. Rim HJ, Chang YS. Chemotherapeutic effect of niclofolan and praziquantel in the treatment of paragonimiasis. Korea Univ Med J 1980;17:113-28.
41. Udonsi JK. Clinical field trials of praziquantel in pulmonary paragonimiasis due to Paragonimus uterobilateralis in endemic populations of the Igwun Basin, Nigeria. Trop Med Parasitol 1989;40:65-8.
42. Bunnag D, Radomyos P, Harinasuta T. Field trial on the treatment of fasciolopsiasis with praziquantel. Southeast Asian J Trop Med Public Health 1983;14:216-9.
43. Hong ST, Cho TK, Hong SJ, Chai JY, Lee SH, Seo BS. Fifteen human cases of Fibricola seoulensis infection in Korea. Kisaengchunghak Chapchi 1984;22:61-5.
44. Lee SK, Chung NS, Ko IH, Sohn WM, Hong ST, Chai JY, Lee SH. An epidemiological survey of Echinostoma hortense infection in Chongsong-gun, Kyongbuk Province. Kisaengchunghak Chapchi 1988;26:199-206.
45. Lee SH, Chai JY, Lee HJ, Hong ST, Yu JR, Sohn WM, Kho WG, Choi MH, Lim YJ. High prevalence of Gymnophalloides seoi infection in a village on a southwestern island of the Republic of Korea. Am J Trop Med Hyg 1994;51:281-5.
46. Chai JY, Nam HK, Kook J, Lee SH. The first discovery of an endemic focus of Heterophyes nocens (Heterophyidae) infection in Korea. Korean J Parasitol 1994;32:157-61.
47. Chai JY, Han ET, Park YK, Guk SM, Lee SH. Acanthoparyphium tyosenense: the discovery of human infection and identification of its source. J Parasitol 2001;87:794-800.
48. Rim HJ, Park SB, Lee JS, Joo KH. Therapeutic effects of praziquantel (Embay 8440) against Taenia solium infection. Kisaengchunghak Chapchi 1979;17:67-72.
49. Chai JY, Sohn WM, Hong SJ, Lee SH, Seo BS. Anthelmintic effect of praziquantel (Cestocide@) in the treatment of Taenia saginata and Diphyllobothrium latum infection. J Korean Soc Chemother 1985;3:181-4.
50. Schenone H, Galdames M, Rivadeneira A, Morales E, Hoffmann MT, Asalgado N, Meneses G, Mora MV, Cabrera G. Treatment of Hymenolepis nana infection in children by a single oral dose of praziquantel (Embay 8440). Bol Chile Parasitol 1977;32:11-3.
51. Rim HJ, Park CY, Lee JS, Joo KH, Lyu KS. Therapeutic effects of praziquantel (Embay 8440) against Hymenolepis nana infection. Kisaengchunghak Chapchi 1978;16:82-7.
52. Schenone H. Praziquantel in the treatment of Hymenolepis nana infection in children. Am J Trop Med Hyg 1980;29:320-1.
53. Rim HJ. Treatment of Hymenolepis nana infection. Postgraduate Doctor-Asia 1981:67-72.
54. Park CY, Joo KH, Rim HJ. Clinical observation on the chemotherapy of cerebral cysticercosis. Korea Univ Med J 1982;19:595-616.
55. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. New Eng J Med 1984;310:1001-7.
56. del Brutto OH, Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report. J Neurosurg 1990;72:816-7.
57. Takayanagui OM, Odashima NS, Bonato PS, Lima JE, Lanchote VL. Medical management of neurocysticercosis. Expert Opin Pharmacother 2011;12:2845-56.
58. Santos R, Chavarria M, Aguirre AE. Failure of medical treatment in two cases of intraocular cysticerscosis. Am J Ophthalmol 1984;97:249-50.
59. Chai JY, Yu JR, Lee SH, Kim SI, Cho SY. Ineffectiveness of praziquantel treatment for human sparganosis: a case report. Seoul J Med 1988;29:397-9.
60. Sohn WM, Hong ST, Chai JY, Lee SH. Infectivity of the sparganum treated by praziquantel, gamma-irradiation and mechanical cutting. Korean J Parasitol 1993;31:135-9.
61. Tanaka S, Maruyama H, Ishiwata K, Nawa Y. A case of pleural sparganosis. Parasitol Int 1997;46:73-5.
62. Ishii H, Mukae H, Inoue Y, Kadota JI, Kohno S, Uchiyama F, Nawa Y. A rare case of eosinophilic pleuritis due to sparganosis. Intern Med 2001;40:783-5.
63. Lee JH, Kim GH, Kim SM, Lee SY, Lee WY, Bae JW, Shin KS, Hwang KK, Kim DW, Cho MC. A case of sparganosis that presented as a recurrent pericardial effusion. Korean Circ J 2011;41:38-42.
64. Haralabidis S, Diakou A, Frydas S, Papadopoulos E, Mylonas A, Patsias A, Roilides E, Giannoulis E. Long-term evaluation of patients with hydatidosis treated with albendazole and praziquantel. Int J Immunopathol Pharmacol 2008;21:429-35.
65. Tekin R, Kara AF, Tekin RC, Cimen D. Cardiac hydatid cyst case recovered with medical treatment. Anadolu Kardiyol Derg 2011;11:650-1.
66. Shaw JG, Aggarwal N, Acosta LP, Jiz MA, Wu HW, Leenstra T, Coutinho HM, Olveda RM, Kurtis JD, McGarvey ST, Friedman JF. Reduction in hookworm infection after praziquantel treatment among children and young adults in Leyte, the Philippines. Am J Trop Med Hyg 2010;83:416-21.
67. Mehlhorn H, Frenkel JK, Andrews P, Thomas H. Light and electron microscopic studies on Schistosoma mansoni granulomas of mouse livers following treatment with praziquantel. Tropenmed Parasitol 1982;33:229-39.
68. Cheever AW, Deb S. Persistence of hepatic fibrosis and tissue eggs following treatment of Schistosoma japonicum infected mice. Am J Trop Med Hyg 1989;40:620-8.
69. Cheever AW, Macedonia JG, Deb S, Cheever EA, Mosimann JE. Persistence of eggs and hepatic fibrosis after treatment of Schistosoma mansoni-infected mice. Am J Trop Med Hyg 1992;46:752-8.
70. Lee SH, Chai JY, Yang EC, Yun CK, Hong ST, Lee JB. Observation of liver pathology after praziquantel treatment in experimental Clonorchis sinensis infection in guinea pigs. Seoul J Med 1988;29:253-62.
71. Lee SH, Hong ST, Kim CS, Sohn WM, Chai JY, Lee YS. Histopathological changes of the liver after praziquantel treatment in Clonorchis sinensis infected rabbits. Kisaengchunghak Chapchi 1987;25:110-22.
72. Lee SH, Kim SY, Han YC, Lee YS, Hong ST, Sohn WM, Chai JY. Effect of praziquantel treatment on pulmonary lesions of rats infected with Paragonimus iloktsuenensis. Kisaengchunghak Chapchi 1989;27:119-30.
73. Lee SH, Kim BI, Hong ST, Sohn WM, Chai JY. Observation of mucosal pathology after praziquantel treatment in experimental Fibricola seoulensis infection in rats. Kisaengchunghak Chapchi 1989;27:35-40.
74. Gustowska L, Pawlowski Z. Histopathological and histoenzymatic studies on experimental Taenia saginata cysticercosis. Vet Parasitol 1981;8:211-8.
75. Hong ST, Lee SH, Lee SJ, Kho WG, Lee M, Chung BS, Seo M, Choi MH. Sustained-release praziquantel tablet: pharmacokinetics and the treatment of clonorchiasis in beagle dogs. Parasitol Res 2003;91:316-20.
76. Lei L, Cheng L, Hou J, Guo S, Zhu C, Shi Y, Jiang Y, Lin J. Prevention of Schistosoma japonicum infection in mice with long-acting praziquantel implants. Exp Parasitol 2012;131:442-7.
77. Rim HJ. The current pathobiology and chemotherapy of clonorchiasis. Kisaengchunghak Chapchi 1986;24 (Suppl): 1-141.
78. Huang SW. A clinical approach to a patient with praziquantel hypersensitivity. J Allergy Clin Immunol 1992;90:867.
79. Shen C, Choi MH, Bae YM, Yu G, Wang S, Hong ST. A case of anaphylactic reaction to praziquantel treatment. Am J Trop Med Hyg 2007;76:603-5.
80. Adam I, Elwasila ET, Homeida M. Is praziquantel therapy safe during pregnancy?. Trans R Soc Trop Med Hyg 2004;98:540-3.
81. Adam I, Elwasila E, Homeida M. Praziquantel for the treatment of schistosomiasis mansoni during pregnancy?. Ann Trop Med Parasitol 2005;99:37-40.
82. Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ. Adult worm tegumental damage and egg-granulomas in praziquantel- resistant and -susceptible Schistosoma mansoni treated in vivo. J Helminthol 2002;76:327-33.
83. Liang YS, Wang W, Dai JR, Li HJ, Tao YH, Zhang JF, Li W, Zhu YC, Coles GC, Doenhoff MJ. Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni. J Helminthol 2010;84:202-7.
84. Wang W, Wang L, Liang YS. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 2012;111:1871-7.
85. Fallon PG, Doenhoff MJ. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 1994;51:83-8.
86. Couto FF, Coelho PM, Araújo N, Kusel JR, Katz N, Jannotti-Passos LK, Mattos AC. Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Mem Inst Oswaldo Cruz 2011;106:153-7.
87. Fallon PG, Sturrock RF, Niang CM, Doenhoff MJ. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 1995;53:61-2.
88. Ismail M, Metwally A, Parghaly A, Bruce J, Tao LF, Bennett JL. Characterization of isolates of Schistosoma mansoni from Egyptian villages that tolerate high doses of praziquantel. Am J Trop Med Hyg 1996;55:214-8.
89. Alonso D, Muñoz J, Gascón J, Valls ME, Corachan M. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am J Trop Med Hyg 2006;74:342-4.
90. Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv Parasitol 2010;73:197-230.
91. Lateef M, Zargar SA, Khan AR, Nazir M, Shoukat A. Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infections with nitazoxanide. Int J Infect Dis 2008;12:80-2.
92. Rim HJ, Chu DS, Lee JS, Joo KH, Won CY. Anthelmintic effects of various drugs against metagonimiasis. Kisaengchunghak Chapchi 1978;16:117-22.
93. Lee SH, Chai JY, Hong SJ, Jun YS, Seo BS. Anthelminti effect of praziquantel (Distocide®) against Metagonimus yokogawai infection. J Korean Soc Chemother 1984;2:167-71.
94. el-Hawy AM, Safwat M, el-Nasr SS, Abdel Rahman MM. The cure rates of patients infected with heterophyiasis and treated with praziquantel versus niclosamide. J Egypt Soc Parasitol 1988;18:437-42.
95. Ata AA, el-Khashab MN, Mourad AA, Soliman HM. The effect of praziquantel on Heterophyes heterophyes, Hymenolepis nana and Fasciola sp. infections. J Egypt Soc Parasitol 1988;18:243-6.
96. Pungpak S, Radomyos P, Radomyos B, Schelp FP, Jongsulsuntigul P, Bunnag D. Treatment of Opisthorchis viverrini and intestinal fluke infections with Praziquantel. Southeast Asian J Trop Med Public Health 1998;29:246-9.